Regulation of miRNA 219 and miRNA Clusters 338 and 17-92 in Oligodendrocytes

MicroRNAs (miRs) regulate diverse molecular and cellular processes including oligodendrocyte (OL) precursor cell (OPC) proliferation and differentiation in rodents. However, the role of miRs in human OPCs is poorly understood. To identify miRs that may regulate these processes in humans, we isolated...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in genetics Vol. 3; p. 46
Main Authors de Faria, Jr, Omar, Cui, Qiao-Ling, Bin, Jenea M, Bull, Sarah-Jane, Kennedy, Timothy E, Bar-Or, Amit, Antel, Jack P, Colman, David R, Dhaunchak, Ajit S
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Research Foundation 2012
Frontiers Media S.A
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:MicroRNAs (miRs) regulate diverse molecular and cellular processes including oligodendrocyte (OL) precursor cell (OPC) proliferation and differentiation in rodents. However, the role of miRs in human OPCs is poorly understood. To identify miRs that may regulate these processes in humans, we isolated OL lineage cells from human white matter and analyzed their miR profile. Using endpoint RT-PCR assays and quantitative real-time PCR, we demonstrate that miR-219, miR-338, and miR-17-92 are enriched in human white matter and expressed in acutely isolated human OLs. In addition, we report the expression of closely related miRs (miR-219-1-3p, miR-219-2-3p, miR-1250, miR-657, miR-3065-5p, miR-3065-3p) in both rodent and human OLs. Our findings demonstrate that miRs implicated in rodent OPC proliferation and differentiation are regulated in human OLs and may regulate myelination program in humans. Thus, these miRs should be recognized as potential therapeutic targets in demyelinating disorders.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
This article was submitted to Frontiers in Non-Coding RNA, a specialty of Frontiers in Genetics.
Edited by: Peng Jin, Emory University School of Medicine, USA
Reviewed by: Yanan Yang, MD Anderson Cancer Center, USA; Bruce Trapp, Cleveland Clinic, USA
ISSN:1664-8021
1664-8021
DOI:10.3389/fgene.2012.00046